Home / Import refusals / FP1-0020719-9/61/1

FDA Import Refusal FP1-0020719-9/61/1 — GlaxoSmithKline Biologicals SA

GlaxoSmithKline Biologicals SA — FEI 3002875226

The FDA refused shipment FP1-0020719-9/61/1 from GlaxoSmithKline Biologicals SA (Belgium) on May 15, 2018. The refused product falls under Drugs and Biologics — HEPATITIS B VACCINE. Cited charges: 118,71 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 15, 2018
Country
Belgium
Product Category
Drugs and Biologics
Product Code
57CH26 HEPATITIS B VACCINE
Charges
118,71

Recent inspections

  • 1215345 (NAI Fri Jun 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1007184 (VAI Fri Jan 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 900625 (VAI Thu Oct 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 818683 (VAI Fri Oct 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 672159 (VAI Thu Jun 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • FP1-0020719-9/121/1 (Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • FP1-0021113-4/161/1 (Fri Mar 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 004-0211549-8/11/1 (Wed Sep 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 004-0177922-9/1/1 (Fri Jul 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 004-0177922-9/2/1 (Fri Jul 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources